ANCA ‐Negative Pauci‐Immune Crescentic Glomerulonephritis With Atypical Endothelial Injury in a Patient With Long‐Standing Rheumatoid Arthritis
Nephrology · 2026-11 · 31 (11)
DOI: 10.1111/nep.70328 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nephrology, online erschienen am 20.11.2026. Verfasst von Takeo Koshida und 9 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Rheumatoid arthritis (RA) is a systemic inflammatory disorder that may be complicated by diverse extra‐articular manifestations, including renal involvement. Anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis (AAV) is an important cause of crescentic glomerulonephritis; however, ANCA‐negative pauci‐immune crescentic glomerulonephritis in patients with RA is uncommon and diagnostically challenging. We herein report a case of ANCA‐negative pauci‐immune crescentic glomerulonephritis with atypical endothelial injury, clinically compatible with renal‐limited AAV in a 70‐year‐old Japanese woman with long‐standing RA. The patient had been treated with methotrexate and iguratimod, and abatacept was subsequently introduced for worsening joint symptoms. Although her articular manifestations improved, renal function began to decline 3 months after abatacept initiation. Laboratory tests showed renal dysfunction accompanied by hematuria and mild proteinuria, whereas serum MPO‐ANCA and PR3‐ANCA were negative. Kidney biopsy revealed crescentic glomerulonephritis with pauci‐immune features, accompanied by prominent endocapillary hypercellularity and glomerular endothelial injury. The renal lesion was considered clinically compatible with ANCA‐negative renal‐limited AAV. Immunosuppressive therapy, including steroid pulse therapy, rituximab and avacopan, was initiated, leading to improvement in renal function and systemic inflammation. This case highlights the importance of kidney biopsy and careful clinicopathological assessment in patients with RA who develop unexplained renal impairment. Even in the absence of MPO‐ANCA or PR3‐ANCA, ANCA‐negative pauci‐immune crescentic glomerulonephritis clinically compatible with renal‐limited AAV should be considered, even when atypical endothelial injury is present.
Zitieren
APA
Koshida, T., Yamada, K., Haku, A., Ohta, S., Takagi, M., Kobayashi, T., Kihara, M., Saeki, H., Gohda, T., & Suzuki, Y. (2026). ANCA ‐Negative Pauci‐Immune Crescentic Glomerulonephritis With Atypical Endothelial Injury in a Patient With Long‐Standing Rheumatoid Arthritis. Nephrology, 31(11). https://doi.org/10.1111/nep.70328
Vancouver
Koshida T, Yamada K, Haku A, Ohta S, Takagi M, Kobayashi T, et al. ANCA ‐Negative Pauci‐Immune Crescentic Glomerulonephritis With Atypical Endothelial Injury in a Patient With Long‐Standing Rheumatoid Arthritis. Nephrology. 2026;31(11). doi:10.1111/nep.70328
BibTeX
@article{Koshida2026,
author = {Koshida, Takeo and Yamada, Koshi and Haku, Ayaka and Ohta, Sae and Takagi, Miyuki and Kobayashi, Takashi and Kihara, Masao and Saeki, Harumi and Gohda, Tomohito and Suzuki, Yusuke},
title = {ANCA ‐Negative Pauci‐Immune Crescentic Glomerulonephritis With Atypical Endothelial Injury in a Patient With Long‐Standing Rheumatoid Arthritis},
journal = {Nephrology},
year = {2026},
volume = {31},
number = {11},
doi = {10.1111/nep.70328}
}
EUVIMED